f8k060713_oceanbio.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
_____________
 
Form 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): June 7, 2013
 
OCEAN BIO-CHEM, INC.
(Exact name of registrant as specified in charter)
 
Florida
 
0-11102
 
59-1564329
(State or Other Jurisdiction of Incorporation)
 
(Commission File Number)
 
(I.R.S. Employer Identification No.)
 
4041 S.W. 47 Avenue, Fort Lauderdale, Florida 33314
(Address of principal executive offices) (Zip Code)
 
(954) 587-6280
Registrant’s telephone number, including area code:
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 

 
 
Item 5.07. Submission of Matters to a Vote of Security Holders
 
Ocean Bio-Chem, Inc. (the “Company”) held its Annual Meeting of Shareholders on June 7, 2013. The proposals submitted by the Board of Directors to a vote of shareholders, and the final results of the voting on each proposal, are noted below.
 
Proposal No. 1 — Election of Directors:
 
Nominees
 
For
 
Withhold
 
Broker Non-Votes
Jeffrey S. Barocas
 
5,810,216
 
74,745
 
1,618,509
Sonia B. Beard
 
5,845,948
 
39,013
 
1,618,509
Diana Mazuelos Conard
 
5,810,216
 
74,745
 
1,618,509
Gregor M. Dornau
 
5,801,966
 
82,995
 
1,618,509
Peter G. Dornau
 
5,819,326
 
65,635
 
1,618,509
William W. Dudman
 
5,810,216
 
74,745
 
1,618,509
James M. Kolisch
 
5,816,921
 
68,040
 
1,618,509
John B. Turner
 
5,867,426
 
17,535
 
1,618,509
 
Proposal No. 2 — Ratification of Appointment of Independent Registered Public Accounting Firm:
 
For
 
Against
 
Abstain
   
7,496,333
 
5,631
 
1,506
   
 
 
 

 
 
Proposal No. 3 — Approval, on an advisory basis, of the compensation of our named executive officers:
 
For
 
Against
 
Abstain
 
Broker Non-Votes
5,864,331
 
16,090
 
4,540
 
1,618,509
 
Proposal No. 4 — Advisory vote on the frequency of the advisory vote on compensation of our named executive officers:
 
1 Year
 
2 Years
 
3 Years
 
Abstain
 
Broker Non-Votes
5,840,959
 
5,623
 
36,850
 
1,529
 
1,618,509
 
 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
OCEAN BIO-CHEM, INC.
     
     
Date: June 10, 2013
By:
/s/ Jeffrey S. Barocas
   
Jeffrey S. Barocas
   
Chief Financial Officer